Please select the option that best describes you:
Topics:
Gastrointestinal Cancers • Medical Oncology
When will you prescribe 3 v. 6 months of FOLFOX or XELOX for the adjuvant treatment of colon cancer?
The abstract of the pooled meta-analysis is not definitive (JCO 35, 2017: suppl; abstr LBA1), and of the phase III trials (SCOT, TOSCA, Alliance/SWOG 80702, PRODIGE, ACHIEVE, HORG) several are not directly relevant to the US population due to the more standard use of FOLFOX > XELOX in the adjuvant setting.
Answer from: Medical Oncologist at Academic Institution
This set of studies will do more to reduce toxicity for patients than any other studies presented at ASCO this year. Based on these results, I plan on treating stage III patients as follows:
1. For T4 and/or N2 patients, I will continue to recommend FOLFOX or CAPOX for 6 months, and continue to adj...
Sign in or Register to read more
Answer from: Medical Oncologist at Academic Institution
I agree for the most part with Yousuf for shortening to 3 months for those with T3N1 tumors, but I will have a low threshold for recommending 6 months of chemotherapy for any hint of a higher risk. Also for the occasional patient who does desire more aggressive treratment (there are such patien...
Comments
Medical Oncologist at Cancer Center Overlook Hospital
when you offer xelox for 3 months, do you give 3 c...
when you offer xelox for 3 months, do you give 3 c...